New England Journal of Medicine · 1981 · 167 citations · 20 references
MedicineHematologyPathologyHemostasisMolecular PathologySystemic PathologyCoagulation AbnormalitiesCoagulation DisordersCoagulation Factor DeficienciesCoagulation PhysiologyHemostatic DisordersThrombotic DisordersAcquired Coagulation Factor DeficienciesCoagulationCoagulation Factor Replacement TherapyFactor X PhysiologyHemorrhagic ManifestationsHemorrhagic PresentationHereditary Factor X DeficiencyInherited Coagulation Factor Deficiencies
SOME patients with primary (immunoglobulintype) amyloidosis acquire a coagulation disorder characterized by factor X deficiency1 2 3 4 5 6 7 8 9 10 11 12 13 and occasionally factor IX deficiency.12 , 13 These patients may have hemorrhagic complications superimposed on the clinical manifestations of amyloidosis. We have previously demonstrated that the acquired factor X deficiency in this disorder is due to rapid clearance of factor X from the circulating blood, with immobilization of the protein in the vasculature.11 This observation explains why these patients are refractory to replacement therapy involving infusion of plasma and plasma fractions containing factor X. The direct binding of factor X to amyloid fibrils exposed to circulating blood . . .
20
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
Ulrich K. Laemmli · Nature · 1970 · 251.6K citations
The characterization of soluble amyloid prepared in water
Mordechai Pras, Dorothea Zucker‐Franklin, A. Rimon et al. · Journal of Clinical Investigation · 1968 · 644 citations · Full text